Alnylam Pharmaceuticals (ALNY) Enterprise Value Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.74% |
| Dec 31, 2025 | -9.68% |
| Sep 30, 2025 | -8.93% |
| Jun 30, 2025 | -9.21% |
| Mar 31, 2025 | 4.67% |
| Dec 31, 2024 | 8.52% |
| Sep 30, 2024 | 8.43% |
| Jun 30, 2024 | -6.30% |
| Mar 31, 2024 | -13.65% |
| Dec 31, 2023 | -17.47% |
| Sep 30, 2023 | -48.51% |
| Jun 30, 2023 | -12.90% |
| Mar 31, 2023 | -5.46% |
| Dec 31, 2022 | 11.93% |
| Sep 30, 2022 | -18.78% |
| Jun 30, 2022 | -17.63% |
| Mar 31, 2022 | -31.71% |
| Dec 31, 2021 | -30.80% |
| Sep 30, 2021 | -10.77% |
| Jun 30, 2021 | 1.09% |
| Mar 31, 2021 | -44.18% |
| Dec 31, 2020 | -51.14% |
| Sep 30, 2020 | -56.74% |
| Jun 30, 2020 | -53.49% |
| Mar 31, 2020 | -6.16% |
| Dec 31, 2019 | -20.42% |
| Sep 30, 2019 | -23.85% |
| Jun 30, 2019 | -26.06% |
| Mar 31, 2019 | -13.34% |
| Dec 31, 2018 | -34.58% |
| Sep 30, 2018 | -11.34% |
| Jun 30, 2018 | -12.24% |
| Mar 31, 2018 | -46.04% |
| Dec 31, 2017 | -68.98% |
| Sep 30, 2017 | -32.95% |
| Jun 30, 2017 | -80.44% |
| Mar 31, 2017 | -22.84% |
| Dec 31, 2016 | -33.43% |
| Sep 30, 2016 | -32.23% |
| Jun 30, 2016 | -31.07% |
| Mar 31, 2016 | -1.63% |
| Dec 31, 2015 | 0.07% |
| Sep 30, 2015 | 4.09% |
| Jun 30, 2015 | 3.59% |
| Mar 31, 2015 | -53.10% |
| Dec 31, 2014 | -16.43% |
| Sep 30, 2014 | -43.20% |
| Jun 30, 2014 | -32.56% |